can reduce the risk of progression to liver cancer 
and cirrhosis. 
(9) For those who are chronically infected, reg-
ular monitoring can lead to the early detection of 
liver cancer at a stage where cure is still possible. 
Liver cancer is one of the deadliest types of cancer 
and one that has received little funding for research 
and prevention. 
(10) Although the costs of education, research, 
and treatment are not trivial, they are substantially 
less than the annual health care cost attributable to 
hepatitis B in the Unites States, which is estimated 
to be approximately $2.5 billion ($2000 per infected 
person). The lifetime cost of the hepatitis B virus in 
2000—before the availability of most of the current 
therapies—was approximately $80,000 per person 
chronically infected, or more than $100 billion. 
SEC. 3. COMPREHENSIVE HEPATITIS B PREVENTION, EDU-
CATION, RESEARCH, AND MEDICAL MANAGE-
MENT PROGRAM. 
Title III of the Public Health Service Act (42 U.S.C. 
241 et seq.) is amended by adding at the end of the fol-
lowing:
‘‘PART R—COMPREHENSIVE HEPATITIS B PRE-
VENTION, 
EDUCATION, 
RESEARCH, 
AND 
MEDICAL MANAGEMENT PROGRAM 
‘‘SEC. 399AA. PROGRAM DEVELOPMENT. 
‘‘(a) IN GENERAL.—The Secretary shall develop and 
implement a plan for the prevention, control, and medical 
management of hepatitis B, which includes strategies for 
expanded vaccination programs, primary and secondary 
preventive education and training, surveillance and early 
detection, and research. 
‘‘(b) INPUT IN DEVELOPMENT OF PLAN.—In devel-
oping the plan under subsection (a), the Secretary shall— 
‘‘(1) be guided by existing recommendations of 
the Department of Health and Human Services, the 
Centers for Disease Control and Prevention, and the 
National Institutes of Health; and 
‘‘(2) consult with— 
‘‘(A) the Director of the Centers for Dis-
ease Control and Prevention; 
‘‘(B) the Director of the National Insti-
tutes of Health; 
‘‘(C) the Director of the National Cancer 
Institute; 
‘‘(D) the Administrator of the Health Re-
sources and Services Administration;
‘‘(E) the Administrator of the Substance 
Abuse and Mental Health Services Administra-
tion; 
‘‘(F) the heads of other Federal agencies 
or offices providing education services to indi-
viduals with viral hepatitis; 
‘‘(G) medical advisory bodies, such as the 
National Task Force on Hepatitis B: Focus on 
Asian and Pacific Islander Americans, the Na-
tional Viral Hepatitis Roundtable, the Asian 
Liver Center at Stanford University, the Hepa-
titis B Foundation, the American Liver Foun-
dation, Hepatitis Foundation International, and 
the Center for the Study of Asian American 
Health; and 
‘‘(H) the public, including— 
‘‘(i) individuals infected with hepatitis 
B; and 
‘‘(ii) advocates concerned with issues 
related to hepatitis B. 
‘‘(c) BIENNIAL UPDATE OF THE PLAN.— 
‘‘(1) IN GENERAL.—The Secretary shall con-
duct a biannual assessment of the plan developed 
under subsection (a) for the purposes of—
‘‘(A) incorporating into such plan new 
knowledge or observations relating to hepatitis 
B (such as knowledge and observations that 
may be derived from clinical, laboratory, and 
epidemiological research and disease detection, 
prevention, and surveillance outcomes); and 
‘‘(B) addressing gaps in the coverage or ef-
fectiveness of the plan. 
‘‘(2) PUBLICATION
OF
NOTICE
OF
ASSESS-
MENTS.—Not later than October 1 of the first even 
numbered year beginning after the date of enact-
ment of this part, and October 1 of each even num-
bered year thereafter, the Secretary shall publish in 
the Federal Register a notice of the results of the 
assessments conducted under paragraph (1). Such 
notice shall include— 
‘‘(A) a description of any revisions to the 
plan developed under subsection (a) as a result 
of the assessment; 
‘‘(B) an explanation of the basis for any 
such revisions, including the ways in which such 
revisions can reasonably be expected to further 
promote the original goals and objectives of the 
plan; and
‘‘(C) in the case of a determination by the 
Secretary that the plan does not need revision, 
an explanation of the basis for such determina-
tion. 
‘‘SEC. 399BB. ELEMENTS OF PROGRAM. 
‘‘(a) IMMUNIZATION, PREVENTION, AND CONTROL 
PROGRAMS.— 
‘‘(1) IN
GENERAL.—The Secretary, acting 
through the Director of the Centers for Disease 
Control and Prevention, shall support the integra-
tion of activities described in paragraph (2) into ex-
isting clinical and public health programs at State, 
local, and tribal levels (including Asian and non- 
Asian community health clinics, programs for the 
prevention and treatment of HIV/AIDS, sexually 
transmitted diseases, and substance abuse, and pro-
grams for individuals in correctional settings). 
‘‘(2) ACTIVITIES.— 
‘‘(A) VOLUNTARY TESTING PROGRAMS.— 
‘‘(i) IN
GENERAL.—The Secretary 
shall establish a mechanism by which to 
support and promote the development of 
State, local, and tribal voluntary hepatitis 
B testing programs to screen the high 
chronic hepatitis B prevalence populations